Terms: = Leukemia AND TG, Thyroglobulin AND Clinical Outcome
6 results:
1. Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism.
Liu J; Chen G; Pelicano H; Liao J; Huang J; Feng L; Keating MJ; Huang P
Oncotarget; 2016 Nov; 7(44):71378-71389. PubMed ID: 27655686
[TBL] [Abstract] [Full Text] [Related]
2. Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53.
Ogasawara MA; Liu J; Pelicano H; Hammoudi N; Croce CM; Keating MJ; Huang P
Mitochondrion; 2016 Nov; 31():33-39. PubMed ID: 27650502
[TBL] [Abstract] [Full Text] [Related]
3. Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.
Sasazuki T; Inoko H; Morishima S; Morishima Y
Adv Immunol; 2016; 129():175-249. PubMed ID: 26791860
[TBL] [Abstract] [Full Text] [Related]
4. Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia.
Nambu T; Hamada A; Nakashima R; Yuki M; Kawaguchi T; Mitsuya H; Saito H
Biol Pharm Bull; 2011; 34(1):114-9. PubMed ID: 21212528
[TBL] [Abstract] [Full Text] [Related]
5. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
[TBL] [Abstract] [Full Text] [Related]
6. Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
Leukemia; 1992 May; 6(5):375-80. PubMed ID: 1593902
[TBL] [Abstract] [Full Text] [Related]
